Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-19T22:21:44.244Z Has data issue: false hasContentIssue false

EPA-1041 – Hair Cortisol Analysis in Patients with Bipolar Disorder: Towards A New Endophenotype?

Published online by Cambridge University Press:  15 April 2020

A.T. Spijker
Affiliation:
Mood Disorders, PsyQ, Den Haag, Netherlands
L. Manenschijn
Affiliation:
Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands
S. Staufenbiel
Affiliation:
Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands
M.A. Koenders
Affiliation:
Mood Disorders, PsyQ, Den Haag, Netherlands
E. Hoencamp
Affiliation:
Mood Disorders, PsyQ, Den Haag, Netherlands
E. Giltay
Affiliation:
Psychiatry, Leiden University Medical Center, Leiden, Netherlands
E.F.C. Van Rossum
Affiliation:
Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Dysregulation of the hypothalamic-pituitary-adrenal (HPA-)axis is hypothesized to play a role in the pathogenesis of bipolar disorder (BD). Conflicting results have been reported when saliva or serum was used to measure cortisol levels. A recently developed method is to measure cortisol in scalp hair, with one cm of scalp hair representing one month. We studied whether there are differences in long-term hair cortisol levels between BD patients and healthy individuals and whether there are associations between hair cortisol, life events and disease characteristics.

Methods:

Hair samples were collected in 100 BD patients and 195 healthy controls. Long-term cortisol levels were determined in 3 cm hair segments. Saliva samples were collected on two consecutive evenings. Documented disease characteristics were disease state, age of onset, psychiatric co-morbidity, and life events.

Results:

Hair cortisol levels were not statistically different in BD patients compared to healthy controls (p=0.233) and were not associated with the disease state at the moment of sample collection (p=0.978). Clinical characteristics, such as age of onset ≥30 years (p=0.004) and psychiatric co-morbidity (44.87 versus 31.41 pg/mg hair; p=.021), appeared to associate with higher hair cortisol levels. Panic disorder associated with decreased cortisol levels (22.13 versus 34.67 pg/mg hair; p=0.019). The occurrence of recent negative major life events, but not of positive major life events, was associated with an increase in HCC in BD patients.

Type
EPW40 - Bipolar Disorders 2
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.